Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07207564) titled 'Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk' on Sept. 26.
Study Type: Observational
Primary Sponsor: Mayo Clinic
Condition:
Breast Carcinoma
Intervention:
Other: Non-Interventional Study
Recruitment Status: Recruiting
Date of First Enrollment: August 28, 2025
Target Sample Size: 4500
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07207564
Published by HT Digital Content Services with permission from Health Daily Digest....